Organ Dysfunction
9
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
75.0%
-11.6% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (9)
Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey
Thoracic Epidural Analgesia for Acute Pancreatitis With Early Organ Dysfunction
ICU Background Early Awareness for Critical deterioratiON
Organ Dysfunction Score for Obstetric Patients
The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN)
Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)
Evaluation of Toxicity From Stem Cell Transplant
Pharmacology of Exenatide in Pediatric Sepsis
Intraoperative Hypovolemia and Fluid Therapy